Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Autologous CAR–T Cell Manufacturing: Current Standing and Future Directions
Genetic Engineering & Biotechnology News Following the approval of the first chimeric antigen receptor (CAR–T) cell construct by the FDA on August 30, 2017, industry stakeholders have been grappling with the many challenges of commercial-scale manufacturing of these types of therapies. |
